{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T19:14:50Z","timestamp":1774898090035,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.antiviral.2015.09.009","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T10:27:53Z","timestamp":1443263273000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket"],"prefix":"10.1016","volume":"123","author":[{"given":"Heike","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kirchmair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim A.","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga B.","family":"Riabova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Glen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Sauerbrei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Schmidtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.09.009_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0166-3542(91)90001-8","article-title":"A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program","volume":"16","author":"Andries","year":"1991","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.09.009_b0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0022-2836(89)90447-6","article-title":"Three-dimensional structures of drug-resistant mutants of human rhinovirus 14","volume":"207","author":"Badger","year":"1989","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1099\/vir.0.069773-0","article-title":"Genetic and antigenic structural characterization for resistance of echovirus 11 to pleconaril in an immunocompromised patient","volume":"96","author":"Benschop","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0020","series-title":"AMBER 11","author":"Case","year":"2010"},{"key":"10.1016\/j.antiviral.2015.09.009_b0025","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"Collins","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.09.009_b0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.20125","article-title":"Selective inhibitors of picornavirus replication","volume":"28","author":"De Palma","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2015.09.009_b0035","first-page":"1","article-title":"Inhibitors of picornavirus replication","volume":"2","author":"Diana","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.09.009_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0163-7258(89)90028-4","article-title":"Inhibitors of viral uncoating","volume":"42","author":"Diana","year":"1989","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2015.09.009_b0045","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/jm00008a014","article-title":"Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism","volume":"38","author":"Diana","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.09.009_b0050","first-page":"93","article-title":"RNA virus evolution and the control of viral disease. Progress in drug research","volume":"33","author":"Domingo","year":"1989","journal-title":"Fortschr. Arzneimittelforsch."},{"key":"10.1016\/j.antiviral.2015.09.009_b0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0959-437X(05)80323-5","article-title":"Genetic variation and quasi-species","volume":"2","author":"Domingo","year":"1992","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.antiviral.2015.09.009_b0060","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/genetics\/148.4.1667","article-title":"Rates of spontaneous mutation","volume":"148","author":"Drake","year":"1998","journal-title":"Genetics"},{"key":"10.1016\/j.antiviral.2015.09.009_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1021\/ml2002955","article-title":"An orally available 3-ethoxybenzisoxazole capsid binder with clinical activity against human rhinovirus","volume":"3","author":"Feil","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2015.09.009_b0070","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0960-9822(00)00176-7","article-title":"Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design","volume":"4","author":"Grant","year":"1994","journal-title":"Curr. Biol.: CB"},{"key":"10.1016\/j.antiviral.2015.09.009_b0075","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/314758","article-title":"Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants","volume":"179","author":"Groarke","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.09.009_b0080","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1128\/JVI.63.6.2476-2485.1989","article-title":"Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound","volume":"63","author":"Heinz","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0085","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.7041255","article-title":"Rapid evolution of RNA genomes","volume":"215","author":"Holland","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.09.009_b0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/jmbi.1993.1137","article-title":"A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A","volume":"230","author":"Kim","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0095","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/JVI.78.7.3663-3674.2004","article-title":"VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds","volume":"78","author":"Ledford","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2005.08.003","article-title":"Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril","volume":"68","author":"Ledford","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.09.009_b0105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/dki055","article-title":"Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication","volume":"55","author":"Makarov","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2015.09.009_b0110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0969-2126(01)00201-5","article-title":"The structure of coxsackievirus B3 at 3.5 A resolution","volume":"3","author":"Muckelbauer","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2015.09.009_b0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1107\/S0907444995002253","article-title":"Structure determination of coxsackievirus B3 to 3.5 A resolution","volume":"51","author":"Muckelbauer","year":"1995","journal-title":"Acta Crystallogr. D, Biol. Crystallogr."},{"key":"10.1016\/j.antiviral.2015.09.009_b0120","series-title":"Fields Virology","first-page":"839","article-title":"Enteroviruses: plioviruses, coxsackieviruses, echoviruses, and newer enteroviruses","author":"Pallansch","year":"2007"},{"key":"10.1016\/j.antiviral.2015.09.009_b0125","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/JVI.63.5.2002-2007.1989","article-title":"Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors","volume":"63","author":"Pevear","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0130","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.09.009_b0135","series-title":"Fields Virology","first-page":"795","article-title":"Picornaviridae: the viruses and their replication","author":"Racaniello","year":"2007"},{"key":"10.1016\/j.antiviral.2015.09.009_b0140","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2015.09.009_b0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/med.20176","article-title":"The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery","volume":"31","author":"Rollinger","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2015.09.009_b0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0966-842X(02)02383-1","article-title":"Picornavirus-receptor interactions","volume":"10","author":"Rossmann","year":"2002","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(01)00305-6","article-title":"A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1","volume":"95","author":"Schmidtke","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2015.09.009_b0160","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dki263","article-title":"Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment","volume":"56","author":"Schmidtke","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2015.09.009_b0165","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/jmv.20933","article-title":"The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice","volume":"79","author":"Schmidtke","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2008.09.002","article-title":"New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3","volume":"81","author":"Schmidtke","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.09.009_b0175","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1128\/JVI.73.3.1878-1884.1999","article-title":"Independence of evolutionary and mutational rates after transmission of avian influenza viruses to swine","volume":"73","author":"Stech","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0180","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1128\/AAC.03328-14","article-title":"The capsid binder vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication","volume":"58","author":"Tijsma","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.09.009_b0185","series-title":"Fields Virology","first-page":"895","article-title":"Rhinoviruses","author":"Turner","year":"2007"},{"key":"10.1016\/j.antiviral.2015.09.009_b0190","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1128\/JVI.72.2.1210-1218.1998","article-title":"WIN 52035-dependent human rhinovirus 16: assembly deficiency caused by mutations near the canyon surface","volume":"72","author":"Wang","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0195","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1128\/AAC.46.12.3809-3816.2002","article-title":"Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir","volume":"46","author":"Wang","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.09.009_b0200","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/jm0202876","article-title":"An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus","volume":"46","author":"Watson","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.09.009_b0205","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1128\/JVI.01988-05","article-title":"N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells","volume":"80","author":"Zautner","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.09.009_b0210","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1128\/JVI.78.20.11061-11069.2004","article-title":"Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421500220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421500220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T09:35:36Z","timestamp":1653212136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421500220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":42,"alternative-id":["S016635421500220X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.09.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}